Not yet recruiting
Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell Carcinoma
NCT07686744
- Conditions
- Adenocarcinoma, Advanced, Carcinoma, +21 more
- Locations
-
- Peking University First Hospital Beijing, Beijing Municipality, China